Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Temple

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Pharmacoepidemiology and Drug Safety|March 23, 2006
Hy's law: predicting serious hepatotoxicityRobert Temple
Cancer Discovery|March 12, 2013
Q&A: Rajeshwari Sridhara, Robert Temple on trial design. Interviewed by Suzanne RoseRajeshwari Sridhara, Robert Temple
Annals of Internal Medicine|January 4, 2007
BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspectiveRobert Temple, Norman L Stockbridge
Food and Drug Law Journal|February 21, 2014
Commemorating the 50th anniversary of the Drug Amendments of 1962Peter Barton Hutt, Robert Temple
Circulation|April 7, 2005
The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval processDan M Roden, Robert Temple
The New England Journal of Medicine|November 12, 2010
Interaction of clopidogrel and omeprazoleMary Ross Southworth, Robert Temple
Circulation|March 28, 2018
Remembering Dr Ray LipickyRobert M Califf, Robert Temple
The New England Journal of Medicine|December 4, 2014
Evaluating Ebola therapies--the case for RCTsEdward Cox, Luciana Borio, Robert Temple
The AAPS Journal|April 6, 2006
Blood pressure as an example of a biomarker that functions as a surrogateMehul Desai, Norman Stockbridge, Robert Temple
The New England Journal of Medicine|July 4, 2008
Drug-review deadlines and safety problemsClark Nardinelli, Michael Lanthier, Robert Temple
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Pharmacoepidemiology and Drug Safety|March 23, 2006
Hy's law: predicting serious hepatotoxicityRobert Temple
Cancer Discovery|March 12, 2013
Q&A: Rajeshwari Sridhara, Robert Temple on trial design. Interviewed by Suzanne RoseRajeshwari Sridhara, Robert Temple
Annals of Internal Medicine|January 4, 2007
BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspectiveRobert Temple, Norman L Stockbridge
Food and Drug Law Journal|February 21, 2014
Commemorating the 50th anniversary of the Drug Amendments of 1962Peter Barton Hutt, Robert Temple
Circulation|April 7, 2005
The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval processDan M Roden, Robert Temple
The New England Journal of Medicine|November 12, 2010
Interaction of clopidogrel and omeprazoleMary Ross Southworth, Robert Temple
Circulation|March 28, 2018
Remembering Dr Ray LipickyRobert M Califf, Robert Temple
The New England Journal of Medicine|December 4, 2014
Evaluating Ebola therapies--the case for RCTsEdward Cox, Luciana Borio, Robert Temple
The AAPS Journal|April 6, 2006
Blood pressure as an example of a biomarker that functions as a surrogateMehul Desai, Norman Stockbridge, Robert Temple
The New England Journal of Medicine|July 4, 2008
Drug-review deadlines and safety problemsClark Nardinelli, Michael Lanthier, Robert Temple
Pageof 9